Fatigue in multiple sclerosis: Interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability

Journal of the Neurological Sciences

Volumn 160, Issue 2, 1998, Pages 164-170

  Van Der Werf, S P ^a   Jongen, P J H ^a   Lycklama A Nijeholt G J ^b   Barkhof, F ^b   Hommes, O R ^a   Bleijenberg, G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Disability; Fatigue; MRI; Multiple sclerosis

Indexed keywords

AMANTADINE; BETA1A INTERFERON; PEMOLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; DISABILITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE;

ADULT; BRAIN; DISABILITY EVALUATION; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS;

EID: 0032497631     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00251-2     Document Type: Article

References (32)

1. The Canadian MS Research Group. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci 1987;14:273-278.
2. Cohen RA, Fisher M Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol. 46:1989;676-680.
3. Colosimo C, Millefiorini E, Grasso MG, Vinci F, Fiorelli M, Koudriavtseva Tet al. Fatigue in multiple sclerosis is associated with specific clinical features. Acta Neurol Scand. 92:1995;353-355.
4. Comi G, Filippi M, Martinelli V, Sirabian G, Visciani A, Campi Aet al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci. 115:1993;66-73.
5. Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni Met al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci. 132:1994;222-227.
6. Damien MS, Schilling G, Bachman G, Simon C, Stoppler S, Dorndorf W White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol Scand. 90:1994;430-436.
7. Durelli L, Bongioanni MR, Cavallo R, Ferrero B, Ferri R, Verdun Eet al. Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function. Multiple Sclerosis. 1:1995;32-37.
8. 2-weighted brain MRI activity in multiple sclerosis. Neurology. 45:1994;255-260.
9. Fillipi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis [Review]. Brain. 118:1995;1601-1612.
10. Fillipi M, Campi A, Martinelli V, Rodeghter M, Scotti G, Canal Net al. A brain MRI study of different types of chronic-progressive multiple sclerosis. Acta Neurol Scand. 91:1995;231-233.
11. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 21:1994;9-14.
12. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 18(Suppl I):1994;79-83.
13. Freal JG, Kraft GH, Coryell JK Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehab. 5:1984;135-137.
14. Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol. 53:1996;185-188.
15. Kersten P, McLellan DL Evidence for a central mechanism in the process of fatigue in patients with multiple sclerosis. Clin Rehab. 10:1996;233-239.
16. Khoury SJ, Guttman CRG, Orav EJ, Hohol MJ, Ahn SS, Hsu Let al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology. 44:1994;2120-2124.
17. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD The fatigue severity scale. Arch Neurol. 46:1989;1121-1123.
18. Kurtzke JF Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 33:1983;1444-1452.
19. Leys D, Pruvo JP, Petit H, Gaudet Y, Clarisse J Maladie d'Alzheimer. Analyse statistique des resultats du scanner X. Rev Neurol (Paris). 145:1989;134-139.
20. Losseff NA, Wang L, Lai HM, et al. A serial MRI study of cerebral atrophy in multiple sclerosis (abstract). Proc Int Soc Magn Res Med 1996:549.
21. Moller A, Wiedemann G, Rohde U, Backmund H, Sonntag A Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand. 89:1994;117-121.
22. Olson T Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J Immunol. 40:1992;211-218.
23. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GCet al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 13:1983;227-231.
24. Sheean G.L., Murray N.M.F., Rothwell J.C., Miller D.H., Thompson A.J. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain. 120:1997;299-315.
25. Sinnige LGF, Teeuwissen E, Hew JM, Minderhoud JM Correlation between magnetic resonance imaging and clinical parameters in multiple sclerosis. Acta Neurol Scand. 91:1995;188-191.
26. Schwartz JE, Jandorf L, Krupp LB The measurement of fatigue: a new instrument. J Psychosom Res. 37:1993;753-762.
27. Schwartz CE, Coulthard-Morris L, Zeng Q Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehab. 77:1996;165-170.
28. Sipe JC, Knobler RL, Braheney SLet al. A neurological rating scale (NRS) for use in multiple sclerosis. Neurology. 34:1984;1368-1372.
29. Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G Dimensional assessment of chronic fatigue syndrome. J Psychsom Res. 38:1994;383-392.
30. Vercoulen JHMM, Hommes OR, Swanink CMA, Jongen PJH, Fennis JFM, Galama JMDet al. The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol. 53:1996;642-649.
31. Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GPA A double-blind randomized crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology. 42:1992;1468-1471.
32. Neilley L.K., Goodin D.S., Goodkin D.E., Hauser S.L. Side effect profile of viterferon beta-1b in MS: results of an open label trial. Neurology. 46(2):1996;552-554.